START FREE TRIAL
Home Healthcare Intuitive Surgical Inc.

Intuitive Surgical Inc.

$19.00

SKU: ISRG-1 Category:

Description

Intuitive Surgical Is Not Just A da Vinci Story — ION Procedures Jump 36%!

 

Intuitive Surgical, Inc. reported results for the second quarter of 2026 reflecting mixed dynamics across its robotic surgical platforms and markets. Total procedures increased 16%, driven by 15% growth in da Vinci procedures and 36% growth in ION procedures. The global installed base expanded, reaching nearly 13,000 systems, with the company placing 468 da Vinci systems and 55 ION systems during the quarter. Adoption of newer platforms such as da Vinci 5, single port (SP), and ION showed strength, supported by product updates and expanded clinical indications. The launch of extended use instrumentation is planned for early 2027, aiming to reduce costs in benign procedures and potentially widen access, particularly in cost-sensitive markets. Financially, Intuitive Surgical posted revenue growth of 19% to $2.89 billion, with recurring revenue comprising 85% of total revenue. Non-GAAP operating margin was 42%, and non-GAAP earnings per share increased 28% year-over-year.